| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |